Urinalysis Market Size Worth $7.85 Billion By 2032 | CAGR: 7.40%

The size of the global urinalysis market was estimated at USD 7.85 billion in 2032 and is anticipated to increase at a CAGR of 7.40% from 2024 to 2032.The report “Urinalysis Market Share, Size, Trends, Industry Analysis Report, By Product (Instrument, Consumables); By Application; By Region; Segment Forecast, 2024-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market for urine testing is growing as a result of factors like the rising incidence of conditions like diabetes, kidney illness, and urinary tract infections (UTIs). The expanded use of sophisticated and automated The National Diabetes Statistical Report, 2020 estimates that 34.2 million adults in the United States have diabetes. Around one-third of those with diabetes also have kidney-related comorbidities because of high blood sugar and blood pressure.

The market for urinalysis was mostly unaffected by the early COVID-19 pandemic due to the low hospitalization rate and declining sales of urine analysis tests. Less people had access to diagnostic and medical services as a result of the government-imposed statewide curfews, which reduced demand for diagnostics products.

An increase in approvals and the release of novel urinalysis instruments are expected to stimulate market growth. For instance, in January 2022, Bio-Rad Laboratories, Inc. introduced the Quantification Advanced Control technology to track the precision urinalysis test method in clinical labs. This equipment increased the efficiency of the laboratory's statistical process control and future product demand.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/urinalysis-market/request-for-sample

The rising importance of urinalysis in the diagnosis of post-COVID-19 diseases, particularly acute kidney & tubular injuries, is expected to fuel market expansion. The kidney injury marker-1 (KIM-1) and urinary NGAL were revealed to be two sensitive biomarkers for identifying patients with tubular and renal injury by the Columbia University study (2021).

Urinalysis Market Report Highlights

• The urinary tract infection segment dominated the market in 2022 due to the rising prevalence of UTIs around the world. Urinary tract infections are thought to affect 150 million individuals annually worldwide, according to the National Library of Medicine.
• A critical screening method to find diabetes is a urinalysis. By 2022, the CDC predicts that 37.3 million Americans will have diabetes. While 8.5 million people go undiagnosed, around 28.7 million people get a diagnosis. As a result, the market is driven by the rising number of diabetes patients.
• North America dominated the market in 2022, accounting for major shares. Its domination may be the result of deliberate decisions made by key players, such as licencing agreements to expand their footprint. For instance, Sysmex and Siemens Healthcare GmbH entered into an exclusive licencing agreement in 2020 to provide hospital and reference laboratories in North America with the automated urine analyzer CLINITEK Novus and support it. This transaction will increase the market.
• Abbott, Sysmex Corporation, ACON Laboratories, ARKRAY Inc., and Quindel Corporation are a few of the prominent competitors in the international market.

Polaris Market Research has segmented the Urinalysis Market report based on product, application, and region:

Urinalysis Market, Product Outlook (Revenue - USD Billion, 2018 - 2030)

• Instrument
• Consumables

 Urinalysis Market, Application Outlook (Revenue - USD Billion, 2018 - 2030)

• Disease Screening.
• Fertility and Pregnancy Testing

Urinalysis Market, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia

• Latin America

• Argentina
• Brazil
• Mexico

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa